Table 1.
Clinical characteristics of patients with IgA nephropathy and healthy controls
| IgAN patients | Healthy controls | P | |
|---|---|---|---|
| No | 40 | 10 | – |
| Age (y) | 36.6±12.9 | 37.3±9.6 | 0.965 |
| Sex (M/F) | 15/25 | 5/5 | 0.134 |
| BMI (kg/m2) | 22.64±3.43 | – | – |
| Albumin (g/dL) | 3.78±0.60 | – | – |
| uKIM-1 (ng/mg Cr) | 1.17±1.51 | 0.29±0.20 | 0.001 |
| Serum creatinine, initial (mg/dL) | 1.12±0.84 | 0.71±0.09 | 0.178 |
| eGFR, initial (mL/min/1.73m2) | 81.6±29.7 | 112.5±11.5 | 0.010 |
| UPCR, initial (g/g Cr) | 1.58±1.47 | – | |
| uRBC grade | – | – | – |
| 0-1/HPF | 3 (7.5) | ||
| 2-4/HPF | 3 (7.5) | ||
| 5-9/HPF | 8 (20.0) | ||
| 10-29/HPF | 11 (27.5) | ||
| many/HPF | 15 (37.5) |
Data are presented as n (%) or mean±SD, unless otherwise indicated.
BMI, body mass index; eGFR, estimated glomerular filtration rate; IgAN, immunoglobulin A nephropathy; HPF, high power field; SD, standard deviation; uKIM-1, urinary kidney injury molecule-1; UPCR, urinary protein/creatinine ratio; uRBC, urine red blood cells.